Global Biopharmaceuticals Market Insights and Forecast to 2031

Report ID: 1198319 | Published Date: Jan 2026 | No. of Page: 126 | Base Year: 2025 | Rating: 3.7 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%)

Impact of U.S Tarrifs Analyzed 2025 

1 Report Business Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Biopharmaceuticals Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
        1.2.2 Monoclonal Antibodies
        1.2.3 Interferon
        1.2.4 Colony-Stimulating Factor
        1.2.5 Erythropoietin
        1.2.6 Insulin
        1.2.7 Vaccines
        1.2.8 Growth Hormones
        1.2.9 Others
    1.3 Market by Application
        1.3.1 Global Biopharmaceuticals Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
        1.3.2 Tumor
        1.3.3 Diabetes
        1.3.4 Cardiovascular
        1.3.5 Hemophilia
        1.3.6 Others
    1.4 Study Objectives
    1.5 Years Considered
2 Global Growth Trends
    2.1 Global Biopharmaceuticals Market Perspective (2017-2028)
    2.2 Biopharmaceuticals Growth Trends by Region
        2.2.1 Biopharmaceuticals Market Size by Region: 2017 VS 2021 VS 2028
        2.2.2 Biopharmaceuticals Historic Market Size by Region (2017-2022)
        2.2.3 Biopharmaceuticals Forecasted Market Size by Region (2023-2028)
    2.3 Biopharmaceuticals Market Dynamics
        2.3.1 Biopharmaceuticals Industry Trends
        2.3.2 Biopharmaceuticals Market Drivers
        2.3.3 Biopharmaceuticals Market Challenges
        2.3.4 Biopharmaceuticals Market Restraints
3 Competition Landscape by Key Players
    3.1 Global Top Biopharmaceuticals Players by Revenue
        3.1.1 Global Top Biopharmaceuticals Players by Revenue (2017-2022)
        3.1.2 Global Biopharmaceuticals Revenue Market Share by Players (2017-2022)
    3.2 Global Biopharmaceuticals Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    3.3 Players Covered: Ranking by Biopharmaceuticals Revenue
    3.4 Global Biopharmaceuticals Market Concentration Ratio
        3.4.1 Global Biopharmaceuticals Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Biopharmaceuticals Revenue in 2021
    3.5 Biopharmaceuticals Key Players Head office and Area Served
    3.6 Key Players Biopharmaceuticals Product Solution and Service
    3.7 Date of Enter into Biopharmaceuticals Market
    3.8 Mergers & Acquisitions, Expansion Plans
4 Biopharmaceuticals Breakdown Data by Type
    4.1 Global Biopharmaceuticals Historic Market Size by Type (2017-2022)
    4.2 Global Biopharmaceuticals Forecasted Market Size by Type (2023-2028)
5 Biopharmaceuticals Breakdown Data by Application
    5.1 Global Biopharmaceuticals Historic Market Size by Application (2017-2022)
    5.2 Global Biopharmaceuticals Forecasted Market Size by Application (2023-2028)
6 North America
    6.1 North America Biopharmaceuticals Market Size (2017-2028)
    6.2 North America Biopharmaceuticals Market Size by Type
        6.2.1 North America Biopharmaceuticals Market Size by Type (2017-2022)
        6.2.2 North America Biopharmaceuticals Market Size by Type (2023-2028)
        6.2.3 North America Biopharmaceuticals Market Share by Type (2017-2028)
    6.3 North America Biopharmaceuticals Market Size by Application
        6.3.1 North America Biopharmaceuticals Market Size by Application (2017-2022)
        6.3.2 North America Biopharmaceuticals Market Size by Application (2023-2028)
        6.3.3 North America Biopharmaceuticals Market Share by Application (2017-2028)
    6.4 North America Biopharmaceuticals Market Size by Country
        6.4.1 North America Biopharmaceuticals Market Size by Country (2017-2022)
        6.4.2 North America Biopharmaceuticals Market Size by Country (2023-2028)
        6.4.3 U.S.
        6.4.4 Canada
7 Europe
    7.1 Europe Biopharmaceuticals Market Size (2017-2028)
    7.2 Europe Biopharmaceuticals Market Size by Type
        7.2.1 Europe Biopharmaceuticals Market Size by Type (2017-2022)
        7.2.2 Europe Biopharmaceuticals Market Size by Type (2023-2028)
        7.2.3 Europe Biopharmaceuticals Market Share by Type (2017-2028)
    7.3 Europe Biopharmaceuticals Market Size by Application
        7.3.1 Europe Biopharmaceuticals Market Size by Application (2017-2022)
        7.3.2 Europe Biopharmaceuticals Market Size by Application (2023-2028)
        7.3.3 Europe Biopharmaceuticals Market Share by Application (2017-2028)
    7.4 Europe Biopharmaceuticals Market Size by Country
        7.4.1 Europe Biopharmaceuticals Market Size by Country (2017-2022)
        7.4.2 Europe Biopharmaceuticals Market Size by Country (2023-2028)
        7.4.3 Germany
        7.4.4 France
        7.4.5 U.K.
        7.4.6 Italy
        7.4.7 Russia
        7.4.8 Nordic Countries
8 Asia-Pacific
    8.1 Asia-Pacific Biopharmaceuticals Market Size (2017-2028)
    8.2 Asia-Pacific Biopharmaceuticals Market Size by Type
        8.2.1 Asia-Pacific Biopharmaceuticals Market Size by Type (2017-2022)
        8.2.2 Asia-Pacific Biopharmaceuticals Market Size by Type (2023-2028)
        8.2.3 Asia-Pacific Biopharmaceuticals Market Share by Type (2017-2028)
    8.3 Asia-Pacific Biopharmaceuticals Market Size by Application
        8.3.1 Asia-Pacific Biopharmaceuticals Market Size by Application (2017-2022)
        8.3.2 Asia-Pacific Biopharmaceuticals Market Size by Application (2023-2028)
        8.3.3 Asia-Pacific Biopharmaceuticals Market Share by Application (2017-2028)
    8.4 Asia-Pacific Biopharmaceuticals Market Size by Region
        8.4.1 Asia-Pacific Biopharmaceuticals Market Size by Region (2017-2022)
        8.4.2 Asia-Pacific Biopharmaceuticals Market Size by Region (2023-2028)
        8.4.3 China
        8.4.4 Japan
        8.4.5 South Korea
        8.4.6 Southeast Asia
        8.4.7 India
        8.4.8 Australia 
9 Latin America
    9.1 Latin America Biopharmaceuticals Market Size (2017-2028)
    9.2 Latin America Biopharmaceuticals Market Size by Type
        9.2.1 Latin America Biopharmaceuticals Market Size by Type (2017-2022)
        9.2.2 Latin America Biopharmaceuticals Market Size by Type (2023-2028)
        9.2.3 Latin America Biopharmaceuticals Market Share by Type (2017-2028)
    9.3 Latin America Biopharmaceuticals Market Size by Application
        9.3.1 Latin America Biopharmaceuticals Market Size by Application (2017-2022)
        9.3.2 Latin America Biopharmaceuticals Market Size by Application (2023-2028)
        9.3.3 Latin America Biopharmaceuticals Market Share by Application (2017-2028)
    9.4 Latin America Biopharmaceuticals Market Size by Country
        9.4.1 Latin America Biopharmaceuticals Market Size by Country (2017-2022)
        9.4.2 Latin America Biopharmaceuticals Market Size by Country (2023-2028)
        9.4.3 Mexico
        9.4.4 Brazil
10 Middle East & Africa
    10.1 Middle East & Africa Biopharmaceuticals Market Size (2017-2028)
    10.2 Middle East & Africa Biopharmaceuticals Market Size by Type
        10.2.1 Middle East & Africa Biopharmaceuticals Market Size by Type (2017-2022)
        10.2.2 Middle East & Africa Biopharmaceuticals Market Size by Type (2023-2028)
        10.2.3 Middle East & Africa Biopharmaceuticals Market Share by Type (2017-2028)
    10.3 Middle East & Africa Biopharmaceuticals Market Size by Application
        10.3.1 Middle East & Africa Biopharmaceuticals Market Size by Application (2017-2022)
        10.3.2 Middle East & Africa Biopharmaceuticals Market Size by Application (2023-2028)
        10.3.3 Middle East & Africa Biopharmaceuticals Market Share by Application (2017-2028)
    10.4 Middle East & Africa Biopharmaceuticals Market Size by Country
        10.4.1 Middle East & Africa Biopharmaceuticals Market Size by Country (2017-2022)
        10.4.2 Middle East & Africa Biopharmaceuticals Market Size by Country (2023-2028)
        10.4.3 Turkey
        10.4.4 Saudi Arabia
        10.4.5 UAE
11 Key Players Profiles
    11.1 Roche
        11.1.1 Roche Company Details
        11.1.2 Roche Business Overview
        11.1.3 Roche Biopharmaceuticals Introduction
        11.1.4 Roche Revenue in Biopharmaceuticals Business (2017-2022)
        11.1.5 Roche Recent Developments
    11.2 Amgen
        11.2.1 Amgen Company Details
        11.2.2 Amgen Business Overview
        11.2.3 Amgen Biopharmaceuticals Introduction
        11.2.4 Amgen Revenue in Biopharmaceuticals Business (2017-2022)
        11.2.5 Amgen Recent Developments
    11.3 AbbVie
        11.3.1 AbbVie Company Details
        11.3.2 AbbVie Business Overview
        11.3.3 AbbVie Biopharmaceuticals Introduction
        11.3.4 AbbVie Revenue in Biopharmaceuticals Business (2017-2022)
        11.3.5 AbbVie Recent Developments
    11.4 Sanofi-Aventis
        11.4.1 Sanofi-Aventis Company Details
        11.4.2 Sanofi-Aventis Business Overview
        11.4.3 Sanofi-Aventis Biopharmaceuticals Introduction
        11.4.4 Sanofi-Aventis Revenue in Biopharmaceuticals Business (2017-2022)
        11.4.5 Sanofi-Aventis Recent Developments
    11.5 Johnson & Johnson
        11.5.1 Johnson & Johnson Company Details
        11.5.2 Johnson & Johnson Business Overview
        11.5.3 Johnson & Johnson Biopharmaceuticals Introduction
        11.5.4 Johnson & Johnson Revenue in Biopharmaceuticals Business (2017-2022)
        11.5.5 Johnson & Johnson Recent Developments
    11.6 Pfizer
        11.6.1 Pfizer Company Details
        11.6.2 Pfizer Business Overview
        11.6.3 Pfizer Biopharmaceuticals Introduction
        11.6.4 Pfizer Revenue in Biopharmaceuticals Business (2017-2022)
        11.6.5 Pfizer Recent Developments
    11.7 Novo Nordisk
        11.7.1 Novo Nordisk Company Details
        11.7.2 Novo Nordisk Business Overview
        11.7.3 Novo Nordisk Biopharmaceuticals Introduction
        11.7.4 Novo Nordisk Revenue in Biopharmaceuticals Business (2017-2022)
        11.7.5 Novo Nordisk Recent Developments
    11.8 Eli Lilly
        11.8.1 Eli Lilly Company Details
        11.8.2 Eli Lilly Business Overview
        11.8.3 Eli Lilly Biopharmaceuticals Introduction
        11.8.4 Eli Lilly Revenue in Biopharmaceuticals Business (2017-2022)
        11.8.5 Eli Lilly Recent Developments
    11.9 Novartis
        11.9.1 Novartis Company Details
        11.9.2 Novartis Business Overview
        11.9.3 Novartis Biopharmaceuticals Introduction
        11.9.4 Novartis Revenue in Biopharmaceuticals Business (2017-2022)
        11.9.5 Novartis Recent Developments
    11.10 Merck
        11.10.1 Merck Company Details
        11.10.2 Merck Business Overview
        11.10.3 Merck Biopharmaceuticals Introduction
        11.10.4 Merck Revenue in Biopharmaceuticals Business (2017-2022)
        11.10.5 Merck Recent Developments
    11.11 Sun
        11.11.1 Sun Company Details
        11.11.2 Sun Business Overview
        11.11.3 Sun Biopharmaceuticals Introduction
        11.11.4 Sun Revenue in Biopharmaceuticals Business (2017-2022)
        11.11.5 Sun Recent Developments
    11.12 3sbio
        11.12.1 3sbio Company Details
        11.12.2 3sbio Business Overview
        11.12.3 3sbio Biopharmaceuticals Introduction
        11.12.4 3sbio Revenue in Biopharmaceuticals Business (2017-2022)
        11.12.5 3sbio Recent Developments
    11.13 Changchun High Tech
        11.13.1 Changchun High Tech Company Details
        11.13.2 Changchun High Tech Business Overview
        11.13.3 Changchun High Tech Biopharmaceuticals Introduction
        11.13.4 Changchun High Tech Revenue in Biopharmaceuticals Business (2017-2022)
        11.13.5 Changchun High Tech Recent Developments
    11.14 CP Guojian
        11.14.1 CP Guojian Company Details
        11.14.2 CP Guojian Business Overview
        11.14.3 CP Guojian Biopharmaceuticals Introduction
        11.14.4 CP Guojian Revenue in Biopharmaceuticals Business (2017-2022)
        11.14.5 CP Guojian Recent Developments
    11.15 Biotech
        11.15.1 Biotech Company Details
        11.15.2 Biotech Business Overview
        11.15.3 Biotech Biopharmaceuticals Introduction
        11.15.4 Biotech Revenue in Biopharmaceuticals Business (2017-2022)
        11.15.5 Biotech Recent Developments
    11.16 Gelgen
        11.16.1 Gelgen Company Details
        11.16.2 Gelgen Business Overview
        11.16.3 Gelgen Biopharmaceuticals Introduction
        11.16.4 Gelgen Revenue in Biopharmaceuticals Business (2017-2022)
        11.16.5 Gelgen Recent Developments
    11.17 Innovent
        11.17.1 Innovent Company Details
        11.17.2 Innovent Business Overview
        11.17.3 Innovent Biopharmaceuticals Introduction
        11.17.4 Innovent Revenue in Biopharmaceuticals Business (2017-2022)
        11.17.5 Innovent Recent Developments
    11.18 Dong Bao
        11.18.1 Dong Bao Company Details
        11.18.2 Dong Bao Business Overview
        11.18.3 Dong Bao Biopharmaceuticals Introduction
        11.18.4 Dong Bao Revenue in Biopharmaceuticals Business (2017-2022)
        11.18.5 Dong Bao Recent Developments
    11.19 Ganlee
        11.19.1 Ganlee Company Details
        11.19.2 Ganlee Business Overview
        11.19.3 Ganlee Biopharmaceuticals Introduction
        11.19.4 Ganlee Revenue in Biopharmaceuticals Business (2017-2022)
        11.19.5 Ganlee Recent Developments
    11.20 United Laboratories
        11.20.1 United Laboratories Company Details
        11.20.2 United Laboratories Business Overview
        11.20.3 United Laboratories Biopharmaceuticals Introduction
        11.20.4 United Laboratories Revenue in Biopharmaceuticals Business (2017-2022)
        11.20.5 United Laboratories Recent Developments
    11.21 SANDOZ (NOVARTIS)
        11.21.1 SANDOZ (NOVARTIS) Company Details
        11.21.2 SANDOZ (NOVARTIS) Business Overview
        11.21.3 SANDOZ (NOVARTIS) Biopharmaceuticals Introduction
        11.21.4 SANDOZ (NOVARTIS) Revenue in Biopharmaceuticals Business (2017-2022)
        11.21.5 SANDOZ (NOVARTIS) Recent Developments
    11.22 Teva Pharmaceutical
        11.22.1 Teva Pharmaceutical Company Details
        11.22.2 Teva Pharmaceutical Business Overview
        11.22.3 Teva Pharmaceutical Biopharmaceuticals Introduction
        11.22.4 Teva Pharmaceutical Revenue in Biopharmaceuticals Business (2017-2022)
        11.22.5 Teva Pharmaceutical Recent Developments
    11.23 Hospira （Pfizer）
        11.23.1 Hospira （Pfizer） Company Details
        11.23.2 Hospira （Pfizer） Business Overview
        11.23.3 Hospira （Pfizer） Biopharmaceuticals Introduction
        11.23.4 Hospira （Pfizer） Revenue in Biopharmaceuticals Business (2017-2022)
        11.23.5 Hospira （Pfizer） Recent Developments
    11.24 MYLAN
        11.24.1 MYLAN Company Details
        11.24.2 MYLAN Business Overview
        11.24.3 MYLAN Biopharmaceuticals Introduction
        11.24.4 MYLAN Revenue in Biopharmaceuticals Business (2017-2022)
        11.24.5 MYLAN Recent Developments
    11.25 Sun pharma
        11.25.1 Sun pharma Company Details
        11.25.2 Sun pharma Business Overview
        11.25.3 Sun pharma Biopharmaceuticals Introduction
        11.25.4 Sun pharma Revenue in Biopharmaceuticals Business (2017-2022)
        11.25.5 Sun pharma Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Author Details
    13.3 Disclaimer

List of Tables
    Table 1. Global Biopharmaceuticals Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
    Table 2. Key Players of Monoclonal Antibodies
    Table 3. Key Players of Interferon
    Table 4. Key Players of Colony-Stimulating Factor
    Table 5. Key Players of Erythropoietin
    Table 6. Key Players of Insulin
    Table 7. Key Players of Vaccines
    Table 8. Key Players of Growth Hormones
    Table 9. Key Players of Others
    Table 10. Global Biopharmaceuticals Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
    Table 11. Global Biopharmaceuticals Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
    Table 12. Global Biopharmaceuticals Market Size by Region (2017-2022) & (US$ Million)
    Table 13. Global Biopharmaceuticals Market Share by Region (2017-2022)
    Table 14. Global Biopharmaceuticals Forecasted Market Size by Region (2023-2028) & (US$ Million)
    Table 15. Global Biopharmaceuticals Market Share by Region (2023-2028)
    Table 16. Biopharmaceuticals Market Trends
    Table 17. Biopharmaceuticals Market Drivers
    Table 18. Biopharmaceuticals Market Challenges
    Table 19. Biopharmaceuticals Market Restraints
    Table 20. Global Biopharmaceuticals Revenue by Players (2017-2022) & (US$ Million)
    Table 21. Global Biopharmaceuticals Revenue Share by Players (2017-2022)
    Table 22. Global Top Biopharmaceuticals by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Biopharmaceuticals as of 2021)
    Table 23. Ranking of Global Top Biopharmaceuticals Companies by Revenue (US$ Million) in 2021
    Table 24. Global 5 Largest Players Market Share by Biopharmaceuticals Revenue (CR5 and HHI) & (2017-2022)
    Table 25. Key Players Headquarters and Area Served
    Table 26. Key Players Biopharmaceuticals Product Solution and Service
    Table 27. Date of Enter into Biopharmaceuticals Market
    Table 28. Mergers & Acquisitions, Expansion Plans
    Table 29. Global Biopharmaceuticals Market Size by Type (2017-2022) & (US$ Million)
    Table 30. Global Biopharmaceuticals Revenue Market Share by Type (2017-2022)
    Table 31. Global Biopharmaceuticals Forecasted Market Size by Type (2023-2028) & (US$ Million)
    Table 32. Global Biopharmaceuticals Revenue Market Share by Type (2023-2028)
    Table 33. Global Biopharmaceuticals Market Size by Application (2017-2022) & (US$ Million)
    Table 34. Global Biopharmaceuticals Revenue Share by Application (2017-2022)
    Table 35. Global Biopharmaceuticals Forecasted Market Size by Application (2023-2028) & (US$ Million)
    Table 36. Global Biopharmaceuticals Revenue Share by Application (2023-2028)
    Table 37. North America Biopharmaceuticals Market Size by Type (2017-2022) & (US$ Million)
    Table 38. North America Biopharmaceuticals Market Size by Type (2023-2028) & (US$ Million)
    Table 39. North America Biopharmaceuticals Market Size by Application (2017-2022) & (US$ Million)
    Table 40. North America Biopharmaceuticals Market Size by Application (2023-2028) & (US$ Million)
    Table 41. North America Biopharmaceuticals Market Size by Country (2017-2022) & (US$ Million)
    Table 42. North America Biopharmaceuticals Market Size by Country (2023-2028) & (US$ Million)
    Table 43. Europe Biopharmaceuticals Market Size by Type (2017-2022) & (US$ Million)
    Table 44. Europe Biopharmaceuticals Market Size by Type (2023-2028) & (US$ Million)
    Table 45. Europe Biopharmaceuticals Market Size by Application (2017-2022) & (US$ Million)
    Table 46. Europe Biopharmaceuticals Market Size by Application (2023-2028) & (US$ Million)
    Table 47. Europe Biopharmaceuticals Market Size by Country (2017-2022) & (US$ Million)
    Table 48. Europe Biopharmaceuticals Market Size by Country (2023-2028) & (US$ Million)
    Table 49. Asia Pacific Biopharmaceuticals Market Size by Type (2017-2022) & (US$ Million)
    Table 50. Asia Pacific Biopharmaceuticals Market Size by Type (2023-2028) & (US$ Million)
    Table 51. Asia Pacific Biopharmaceuticals Market Size by Application (2017-2022) & (US$ Million)
    Table 52. Asia Pacific Biopharmaceuticals Market Size by Application (2023-2028) & (US$ Million)
    Table 53. Asia Pacific Biopharmaceuticals Market Size by Region (2017-2022) & (US$ Million)
    Table 54. Asia Pacific Biopharmaceuticals Market Size by Region (2023-2028) & (US$ Million)
    Table 55. Latin America Biopharmaceuticals Market Size by Type (2017-2022) & (US$ Million)
    Table 56. Latin America Biopharmaceuticals Market Size by Type (2023-2028) & (US$ Million)
    Table 57. Latin America Biopharmaceuticals Market Size by Application (2017-2022) & (US$ Million)
    Table 58. Latin America Biopharmaceuticals Market Size by Application (2023-2028) & (US$ Million)
    Table 59. Latin America Biopharmaceuticals Market Size by Country (2017-2022) & (US$ Million)
    Table 60. Latin America Biopharmaceuticals Market Size by Country (2023-2028) & (US$ Million)
    Table 61. Middle East and Africa Biopharmaceuticals Market Size by Type (2017-2022) & (US$ Million)
    Table 62. Middle East and Africa Biopharmaceuticals Market Size by Type (2023-2028) & (US$ Million)
    Table 63. Middle East and Africa Biopharmaceuticals Market Size by Application (2017-2022) & (US$ Million)
    Table 64. Middle East and Africa Biopharmaceuticals Market Size by Application (2023-2028) & (US$ Million)
    Table 65. Middle East and Africa Biopharmaceuticals Market Size by Country (2017-2022) & (US$ Million)
    Table 66. Middle East and Africa Biopharmaceuticals Market Size by Country (2023-2028) & (US$ Million)
    Table 67. Roche Company Details
    Table 68. Roche Business Overview
    Table 69. Roche Biopharmaceuticals Product
    Table 70. Roche Revenue in Biopharmaceuticals Business (2017-2022) & (US$ Million)
    Table 71. Roche Recent Developments
    Table 72. Amgen Company Details
    Table 73. Amgen Business Overview
    Table 74. Amgen Biopharmaceuticals Product
    Table 75. Amgen Revenue in Biopharmaceuticals Business (2017-2022) & (US$ Million)
    Table 76. Amgen Recent Developments
    Table 77. AbbVie Company Details
    Table 78. AbbVie Business Overview
    Table 79. AbbVie Biopharmaceuticals Product
    Table 80. AbbVie Revenue in Biopharmaceuticals Business (2017-2022) & (US$ Million)
    Table 81. AbbVie Recent Developments
    Table 82. Sanofi-Aventis Company Details
    Table 83. Sanofi-Aventis Business Overview
    Table 84. Sanofi-Aventis Biopharmaceuticals Product
    Table 85. Sanofi-Aventis Revenue in Biopharmaceuticals Business (2017-2022) & (US$ Million)
    Table 86. Sanofi-Aventis Recent Developments
    Table 87. Johnson & Johnson Company Details
    Table 88. Johnson & Johnson Business Overview
    Table 89. Johnson & Johnson Biopharmaceuticals Product
    Table 90. Johnson & Johnson Revenue in Biopharmaceuticals Business (2017-2022) & (US$ Million)
    Table 91. Johnson & Johnson Recent Developments
    Table 92. Pfizer Company Details
    Table 93. Pfizer Business Overview
    Table 94. Pfizer Biopharmaceuticals Product
    Table 95. Pfizer Revenue in Biopharmaceuticals Business (2017-2022) & (US$ Million)
    Table 96. Pfizer Recent Developments
    Table 97. Novo Nordisk Company Details
    Table 98. Novo Nordisk Business Overview
    Table 99. Novo Nordisk Biopharmaceuticals Product
    Table 100. Novo Nordisk Revenue in Biopharmaceuticals Business (2017-2022) & (US$ Million)
    Table 101. Novo Nordisk Recent Developments
    Table 102. Eli Lilly Company Details
    Table 103. Eli Lilly Business Overview
    Table 104. Eli Lilly Biopharmaceuticals Product
    Table 105. Eli Lilly Revenue in Biopharmaceuticals Business (2017-2022) & (US$ Million)
    Table 106. Eli Lilly Recent Developments
    Table 107. Novartis Company Details
    Table 108. Novartis Business Overview
    Table 109. Novartis Biopharmaceuticals Product
    Table 110. Novartis Revenue in Biopharmaceuticals Business (2017-2022) & (US$ Million)
    Table 111. Novartis Recent Developments
    Table 112. Merck Company Details
    Table 113. Merck Business Overview
    Table 114. Merck Biopharmaceuticals Product
    Table 115. Merck Revenue in Biopharmaceuticals Business (2017-2022) & (US$ Million)
    Table 116. Merck Recent Developments
    Table 117. Sun Company Details
    Table 118. Sun Business Overview
    Table 119. Sun Biopharmaceuticals Product
    Table 120. Sun Revenue in Biopharmaceuticals Business (2017-2022) & (US$ Million)
    Table 121. Sun Recent Developments
    Table 122. 3sbio Company Details
    Table 123. 3sbio Business Overview
    Table 124. 3sbio Biopharmaceuticals Product
    Table 125. 3sbio Revenue in Biopharmaceuticals Business (2017-2022) & (US$ Million)
    Table 126. 3sbio Recent Developments
    Table 127. Changchun High Tech Company Details
    Table 128. Changchun High Tech Business Overview
    Table 129. Changchun High Tech Biopharmaceuticals Product
    Table 130. Changchun High Tech Revenue in Biopharmaceuticals Business (2017-2022) & (US$ Million)
    Table 131. Changchun High Tech Recent Developments
    Table 132. CP Guojian Company Details
    Table 133. CP Guojian Business Overview
    Table 134. CP Guojian Biopharmaceuticals Product
    Table 135. CP Guojian Revenue in Biopharmaceuticals Business (2017-2022) & (US$ Million)
    Table 136. CP Guojian Recent Developments
    Table 137. Biotech Company Details
    Table 138. Biotech Business Overview
    Table 139. Biotech Biopharmaceuticals Product
    Table 140. Biotech Revenue in Biopharmaceuticals Business (2017-2022) & (US$ Million)
    Table 141. Biotech Recent Developments
    Table 142. Gelgen Company Details
    Table 143. Gelgen Business Overview
    Table 144. Gelgen Biopharmaceuticals Product
    Table 145. Gelgen Revenue in Biopharmaceuticals Business (2017-2022) & (US$ Million)
    Table 146. Gelgen Recent Developments
    Table 147. Innovent Company Details
    Table 148. Innovent Business Overview
    Table 149. Innovent Biopharmaceuticals Product
    Table 150. Innovent Revenue in Biopharmaceuticals Business (2017-2022) & (US$ Million)
    Table 151. Innovent Recent Developments
    Table 152. Dong Bao Company Details
    Table 153. Dong Bao Business Overview
    Table 154. Dong Bao Biopharmaceuticals Product
    Table 155. Dong Bao Revenue in Biopharmaceuticals Business (2017-2022) & (US$ Million)
    Table 156. Dong Bao Recent Developments
    Table 157. Ganlee Company Details
    Table 158. Ganlee Business Overview
    Table 159. Ganlee Biopharmaceuticals Product
    Table 160. Ganlee Revenue in Biopharmaceuticals Business (2017-2022) & (US$ Million)
    Table 161. Ganlee Recent Developments
    Table 162. United Laboratories Company Details
    Table 163. United Laboratories Business Overview
    Table 164. United Laboratories Biopharmaceuticals Product
    Table 165. United Laboratories Revenue in Biopharmaceuticals Business (2017-2022) & (US$ Million)
    Table 166. United Laboratories Recent Developments
    Table 167. SANDOZ (NOVARTIS) Company Details
    Table 168. SANDOZ (NOVARTIS) Business Overview
    Table 169. SANDOZ (NOVARTIS) Biopharmaceuticals Product
    Table 170. SANDOZ (NOVARTIS) Revenue in Biopharmaceuticals Business (2017-2022) & (US$ Million)
    Table 171. SANDOZ (NOVARTIS) Recent Developments
    Table 172. Teva Pharmaceutical Company Details
    Table 173. Teva Pharmaceutical Business Overview
    Table 174. Teva Pharmaceutical Biopharmaceuticals Product
    Table 175. Teva Pharmaceutical Revenue in Biopharmaceuticals Business (2017-2022) & (US$ Million)
    Table 176. Teva Pharmaceutical Recent Developments
    Table 177. Hospira （Pfizer） Company Details
    Table 178. Hospira （Pfizer） Business Overview
    Table 179. Hospira （Pfizer） Biopharmaceuticals Product
    Table 180. Hospira （Pfizer） Revenue in Biopharmaceuticals Business (2017-2022) & (US$ Million)
    Table 181. Hospira （Pfizer） Recent Developments
    Table 182. MYLAN Company Details
    Table 183. MYLAN Business Overview
    Table 184. MYLAN Biopharmaceuticals Product
    Table 185. MYLAN Revenue in Biopharmaceuticals Business (2017-2022) & (US$ Million)
    Table 186. MYLAN Recent Developments
    Table 187. Sun pharma Company Details
    Table 188. Sun pharma Business Overview
    Table 189. Sun pharma Biopharmaceuticals Product
    Table 190. Sun pharma Revenue in Biopharmaceuticals Business (2017-2022) & (US$ Million)
    Table 191. Sun pharma Recent Developments
    Table 192. Research Programs/Design for This Report
    Table 193. Key Data Information from Secondary Sources
    Table 194. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Biopharmaceuticals Market Share by Type: 2021 VS 2028
    Figure 2. Monoclonal Antibodies Features
    Figure 3. Interferon Features
    Figure 4. Colony-Stimulating Factor Features
    Figure 5. Erythropoietin Features
    Figure 6. Insulin Features
    Figure 7. Vaccines Features
    Figure 8. Growth Hormones Features
    Figure 9. Others Features
    Figure 10. Global Biopharmaceuticals Market Share by Application: 2021 VS 2028
    Figure 11. Tumor Case Studies
    Figure 12. Diabetes Case Studies
    Figure 13. Cardiovascular Case Studies
    Figure 14. Hemophilia Case Studies
    Figure 15. Others Case Studies
    Figure 16. Biopharmaceuticals Report Years Considered
    Figure 17. Global Biopharmaceuticals Market Size (US$ Million), Year-over-Year: 2017-2028
    Figure 18. Global Biopharmaceuticals Market Size, (US$ Million), 2017 VS 2021 VS 2028
    Figure 19. Global Biopharmaceuticals Market Share by Region: 2021 VS 2028
    Figure 20. Global Biopharmaceuticals Market Share by Players in 2021
    Figure 21. Global Top Biopharmaceuticals Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Biopharmaceuticals as of 2021)
    Figure 22. The Top 10 and 5 Players Market Share by Biopharmaceuticals Revenue in 2021
    Figure 23. North America Biopharmaceuticals Market Size YoY (2017-2028) & (US$ Million)
    Figure 24. North America Biopharmaceuticals Market Size Market Share by Type (2017-2028)
    Figure 25. North America Biopharmaceuticals Market Size Market Share by Application (2017-2028)
    Figure 26. North America Biopharmaceuticals Market Size Share by Country (2017-2028)
    Figure 27. United States Biopharmaceuticals Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 28. Canada Biopharmaceuticals Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 29. Europe Biopharmaceuticals Market Size YoY (2017-2028) & (US$ Million)
    Figure 30. Europe Biopharmaceuticals Market Size Market Share by Type (2017-2028)
    Figure 31. Europe Biopharmaceuticals Market Size Market Share by Application (2017-2028)
    Figure 32. Europe Biopharmaceuticals Market Size Share by Country (2017-2028)
    Figure 33. Germany Biopharmaceuticals Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 34. France Biopharmaceuticals Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 35. U.K. Biopharmaceuticals Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 36. Italy Biopharmaceuticals Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 37. Russia Biopharmaceuticals Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 38. Nordic Countries Biopharmaceuticals Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 39. Asia-Pacific Biopharmaceuticals Market Size YoY (2017-2028) & (US$ Million)
    Figure 40. Asia Pacific Biopharmaceuticals Market Size Market Share by Type (2017-2028)
    Figure 41. Asia Pacific Biopharmaceuticals Market Size Market Share by Application (2017-2028)
    Figure 42. Asia Pacific Biopharmaceuticals Market Size Share by Region (2017-2028)
    Figure 43. China Biopharmaceuticals Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 44. Japan Biopharmaceuticals Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 45. South Korea Biopharmaceuticals Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 46. Southeast Asia Biopharmaceuticals Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 47. India Biopharmaceuticals Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 48. Australia Biopharmaceuticals Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 49. Latin America Biopharmaceuticals Market Size YoY (2017-2028) & (US$ Million)
    Figure 50. Latin America Biopharmaceuticals Market Size Market Share by Type (2017-2028)
    Figure 51. Latin America Biopharmaceuticals Market Size Market Share by Application (2017-2028)
    Figure 52. Latin America Biopharmaceuticals Market Size Share by Country (2017-2028)
    Figure 53. Mexico Biopharmaceuticals Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 54. Brazil Biopharmaceuticals Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 55. Middle East & Africa Biopharmaceuticals Market Size YoY (2017-2028) & (US$ Million)
    Figure 56. Middle East and Africa Biopharmaceuticals Market Size Market Share by Type (2017-2028)
    Figure 57. Middle East and Africa Biopharmaceuticals Market Size Market Share by Application (2017-2028)
    Figure 58. Middle East and Africa Biopharmaceuticals Market Size Share by Country (2017-2028)
    Figure 59. Turkey Biopharmaceuticals Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 60. Saudi Arabia Biopharmaceuticals Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 61. UAE Biopharmaceuticals Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 62. Roche Revenue Growth Rate in Biopharmaceuticals Business (2017-2022)
    Figure 63. Amgen Revenue Growth Rate in Biopharmaceuticals Business (2017-2022)
    Figure 64. AbbVie Revenue Growth Rate in Biopharmaceuticals Business (2017-2022)
    Figure 65. Sanofi-Aventis Revenue Growth Rate in Biopharmaceuticals Business (2017-2022)
    Figure 66. Johnson & Johnson Revenue Growth Rate in Biopharmaceuticals Business (2017-2022)
    Figure 67. Pfizer Revenue Growth Rate in Biopharmaceuticals Business (2017-2022)
    Figure 68. Novo Nordisk Revenue Growth Rate in Biopharmaceuticals Business (2017-2022)
    Figure 69. Eli Lilly Revenue Growth Rate in Biopharmaceuticals Business (2017-2022)
    Figure 70. Novartis Revenue Growth Rate in Biopharmaceuticals Business (2017-2022)
    Figure 71. Merck Revenue Growth Rate in Biopharmaceuticals Business (2017-2022)
    Figure 72. Sun Revenue Growth Rate in Biopharmaceuticals Business (2017-2022)
    Figure 73. 3sbio Revenue Growth Rate in Biopharmaceuticals Business (2017-2022)
    Figure 74. Changchun High Tech Revenue Growth Rate in Biopharmaceuticals Business (2017-2022)
    Figure 75. CP Guojian Revenue Growth Rate in Biopharmaceuticals Business (2017-2022)
    Figure 76. Biotech Revenue Growth Rate in Biopharmaceuticals Business (2017-2022)
    Figure 77. Gelgen Revenue Growth Rate in Biopharmaceuticals Business (2017-2022)
    Figure 78. Innovent Revenue Growth Rate in Biopharmaceuticals Business (2017-2022)
    Figure 79. Dong Bao Revenue Growth Rate in Biopharmaceuticals Business (2017-2022)
    Figure 80. Ganlee Revenue Growth Rate in Biopharmaceuticals Business (2017-2022)
    Figure 81. United Laboratories Revenue Growth Rate in Biopharmaceuticals Business (2017-2022)
    Figure 82. SANDOZ (NOVARTIS) Revenue Growth Rate in Biopharmaceuticals Business (2017-2022)
    Figure 83. Teva Pharmaceutical Revenue Growth Rate in Biopharmaceuticals Business (2017-2022)
    Figure 84. Hospira （Pfizer） Revenue Growth Rate in Biopharmaceuticals Business (2017-2022)
    Figure 85. MYLAN Revenue Growth Rate in Biopharmaceuticals Business (2017-2022)
    Figure 86. Sun pharma Revenue Growth Rate in Biopharmaceuticals Business (2017-2022)
    Figure 87. Bottom-up and Top-down Approaches for This Report
    Figure 88. Data Triangulation
    Figure 89. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Roche
Amgen
AbbVie
Sanofi-Aventis
Johnson & Johnson
Pfizer
Novo Nordisk
Eli Lilly
Novartis
Merck
Sun
3sbio
Changchun High Tech
CP Guojian
Biotech
Gelgen
Innovent
Dong Bao
Ganlee
United Laboratories
SANDOZ (NOVARTIS)
Teva Pharmaceutical
Hospira （Pfizer）
MYLAN
Sun pharma
Frequently Asked Questions
Biopharmaceuticals report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Biopharmaceuticals report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Biopharmaceuticals report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

Nylon Copolymer

Nylon Copolymer market is segmented by Type and by Application. Players, stakeholders, and other  ... Read More

Outdoor Cushions

Outdoor Cushions market is segmented by Type and by Application. Players, stakeholders, and other ... Read More